Publicaciones en colaboración con investigadores/as de Hospital Severo Ochoa (10)

2014

  1. MicroRNA-dependent regulation of transcription in non-small cell lung cancer

    PLoS ONE, Vol. 9, Núm. 3

2012

  1. A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

    Clinical and Translational Oncology, Vol. 14, Núm. 8, pp. 606-612

2011

  1. Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

    Clinical and Translational Oncology, Vol. 13, Núm. 3, pp. 179-184

2010

  1. Expression of EGFR, HER-2/neu and KIT in germ cell tumours

    Clinical and Translational Oncology, Vol. 12, Núm. 6, pp. 443-449

2008

  1. Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer

    Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 52-57

2007

  1. Fluorouracil-based chemotherapy in patients with gastrointestinal malignancies: Influence of nutritional folate status on toxicity

    Journal of Chemotherapy, Vol. 19, Núm. 6, pp. 744-749

  2. Prognostic value of KIT expression in small cell lung cancer

    Lung Cancer, Vol. 56, Núm. 3, pp. 405-413

2006

  1. Polymorphisms in DNA repair genes modulate survival in cisplatin/ gemcitabine-treated non-small-cell lung cancer patients

    Annals of Oncology, Vol. 17, Núm. 4, pp. 668-675

  2. Systemic chemotherapy in the management of malignant peritoneal mesothelioma

    European Journal of Surgical Oncology, Vol. 32, Núm. 6, pp. 676-681

2002

  1. La molécula STI-571 y su implicación en el tratamiento del cáncer

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 5, Núm. 1, pp. 23-25